Medical Communications

Showing 15 posts of 6402 posts found.

Cambridge’s Experimental Cancer Medicine Centre to receive funding for clinical trials

January 18, 2023 Medical Communications

The Experimental Cancer Medicine Centre (ECMC) in Cambridge is one of a selection of organisations to receive a share of …

UCL to begin new trial to assess cough medicine’s impact on Parkinson’s disease

January 17, 2023 Medical Communications

Researchers led by a team at University College London (UCL) have began researching the impacts of ambroxol, a common ingredient …

Thermo Fisher to become founding sponsor of Momentum Labs

January 17, 2023 Medical Communications

Thermo Fisher Scientific has announced that it has become a founding sponsor of Momentum Labs in Alachua, Florida, US. The …

Indonesia begins hearing class-action lawsuit after children’s deaths from cough syrup

January 17, 2023 Medical Communications

An Indonesian court has begun proceedings to hear a class-action lawsuit against health and finance ministries, the drugs regulator and …

Boehringer Ingelheim and 3T Biosciences form $268m partnership to develop next-generation cancer immunotherapies

January 16, 2023 Medical Communications

Germany-based Boehringer Ingelheim and US company 3T Biosciences have entered into a strategic collaboration and licensing agreement to research and …

Eli Lilly and AbbVie leave UK VPAS; blow to UK pharma industry

January 16, 2023 Medical Communications

Eli Lilly and AbbVie have announced their departure from the voluntary scheme for branded medicines pricing and access (VPAS), causing …

Pfizer’s COVID-19 vaccine under FDA’s examination following new research into adverse side effects

January 13, 2023 Medical Communications

The FDA, along with Taiwanese medical institutions, have been evaluating Pfizer’s mRNA COVID-19 vaccine, questioning the CDC’s omission of known …

Diabeloop and EOFlow team up to develop an automated insulin device

January 13, 2023 Medical Communications

Diabeloop, a medical device company focused on automated diabetes treatment solutions, and South Korea-based EOFlow have joined forces to offer …

BD showcase new-generation robotic track system for microbiology labs

January 12, 2023 Medical Communications

US-based Becton, Dickinson and Company (BD) has revealed new-generation robotic track system for its BD Kiestra microbiology laboratory solution which …

FDA clears first ACL reconstruction device for use in paediatric patients

January 11, 2023 Medical Communications

The FDA has cleared the ACL TightRope® II implant to treat torn knee ligaments in children and adolescents. The implant …

BioNTech acquires AI company InstaDeep for £562m

January 11, 2023 Medical Communications

Germany-based BioNTech has acquired UK AI start up InstaDeep for £562m after a multi-year partnership. The acquisition is part of …

Insilico Medicine shares positive topline results of phase 1 trial of AI-designed drug for AI-discovered target

January 10, 2023 Medical Communications

Clinical stage AI-driven drug R&D company, Insilico Medicine, has announced positive topline results from its phase 1 trial assessing the …

FDA issues Emergency Use Authorisation for BD and CerTest Biotec’s Monkeypox PCR test

January 10, 2023 Medical Communications

US medical technology company BD and Spanish biotechnology company CerTest Biotec have joined forces to develop a real-time Monkeypox test …

NHS to offer artificial pancreas to type 1 diabetes patients

January 10, 2023 Medical Communications

The NHS will soon be offering an artificial pancreas to more than 100,000 people with type 1 diabetes across England …

BioNTech and UK Government announce strategic partnership to provide mRNA cancer immunotherapies

January 6, 2023 Medical Communications

German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU) which will accelerate clinical trials …
The Gateway to Local Adoption Series

Latest content